Microwave ablation and uterine artery embolization are being compared for symptomatic adenomyosis. A Swedish randomized pilot study enrolled 20 participants. Its symptom findings do not establish better fertility or signal the end of surgery; treatment choice still depends on the clinical goal.
A Swedish pilot trial compared two uterus-preserving approaches for symptomatic adenomyosis. It asks a useful question about symptoms; it does not announce the end of excision.
The randomized study enrolled 20 premenopausal participants at Danderyd Hospital. Microwave ablation applies heat, whereas uterine artery embolization reduces blood supply. The small sample limits broad claims of superiority.
A comparison of recovery experiences is not automatically a comparison of future reproductive outcomes.
Adenomyosis care can involve medical, interventional or surgical approaches. Symptoms and pregnancy plans help frame the comparison; removing tissue has never been the only goal of every treatment.
Energy-based treatment offers a compelling answer to these questions. Instead of aiming for total eradication of the lesion, it focuses on reducing its size and mitigating symptoms to maintain the integrity of the uterine structure. In short, the paradigm is shifting from “cure” to “management.”
Preserving the uterus is an important goal for some patients, but it is not equivalent to preserving or improving fertility. Pregnancy outcomes require their own evidence.
Available choices should be compared by symptoms, anatomy, risks and reproductive plans. Less invasive does not mean universally preferable.
However, a critical prerequisite remains: there is no “universal treatment” applicable to every patient. Strategies must be tailored based on the location and extent of the lesion, the state of the uterus, and the patient’s pregnancy plans.
The appropriate benchmark depends on the patient’s goal. Symptom relief, recovery, recurrence and live birth should not be collapsed into one definition of success.
Disclaimer: This content is provided for informational purposes, based on reporting on infertility and various public data. Medical judgments and treatment decisions must always be made in consultation with professional medical personnel. Image: AI-generated (ChatGPT, OpenAI) / Visual reference for illustrative purposes only.
A 20-participant pilot—not a fertility trial
The Swedish randomized pilot trial enrolled 20 premenopausal participants with symptomatic adenomyosis at Danderyd Hospital. Published in PLOS ONE in 2026 (DOI: 10.1371/journal.pone.0343949), it compared MWA and UAE. Its small size and symptom focus limit conclusions about reproductive outcomes. Primary report: MWA versus UAE for adenomyosis.
Related reading
Adenomyosis, Fibroids and IVF: What a Pregnancy-Loss Study Shows
English visual adaptation: AI-generated conceptual illustration. It is not a clinical image, product endorsement or photograph documenting the cited study.